全球医用导管市场：2025-2030 年预测

预计医用导管市场规模将从 2025 年的 93.79 亿美元成长至 2030 年的 135.93 亿美元，复合年增长率为 7.70%。

慢性病增多

慢性疾病负担日益加重，尤其是心血管疾病 (CVD)，是医用导管市场的主要驱动力。根据世界卫生组织 (WHO) 统计，心血管疾病每年导致 1,790 万人死亡，占全球死亡率的 31%。吸烟、不健康饮食和缺乏运动等风险因素会增加心臟病发作和中风的发生率，因此需要先进的医疗干预措施。医用导管对于液体管理、引流和药物输送至关重要，包括在心臟治疗设备中用于管理心率。肥胖导致的心臟疾病高发生率也进一步推动了对诊断和治疗医用导管的需求，从而促进了市场成长。

全球人口老化

人口快速老化，尤其是65岁以上的老年人，显着增加了对医用导管的需求。这群人易患慢性疾病，需要导管和输液系统等先进的医疗保健解决方案。联合国预测，到2050年，全球60岁以上人口将达到21亿，预计2023年将显着成长。这些人口结构变化给医疗保健系统带来压力，推高了医疗成本，并推动了从慢性病管理到微创手术等广泛应用领域对医用导管的需求。

政府对医疗保健的投资

政府的优惠政策和对医疗基础设施的投资正在推动市场成长。尤其是在新兴市场，为提高医疗可近性所做的努力，正在推动依赖医用导管的先进医疗设备的普及。例如，印度2024年的医疗保健预算已拨出大量资金用于扩大三级医疗机构，这推动了专科护理领域对医用导管的需求。同样，全球范围内为改善慢性病管理的医疗服务所做的努力也在推动市场扩张。

微创手术的发展

微创手术的日益普及是主要的成长动力。这些手术高度依赖医用导管，例如导管、内视镜和药物输送系统，缩短了恢復时间并降低了併发症发生率。微创手术的趋势，尤其是在心血管和肿瘤治疗领域，正在推动对确保精准度和生物相容性的专用导管材料的需求。

药品输送产业的扩张

在标靶给药系统创新的推动下，药物传输领域正经历强劲成长。医用导管在精准给药方面发挥着至关重要的作用，尤其是在慢性病管理方面。到2024年，主要企业将推出用于标靶给药的先进导管解决方案，从而提高治疗效果和患者预后，进一步推动市场成长。

市场区隔分析

远端患者监护

远端患者监护(RPM) 的兴起是市场的关键驱动力，尤其是在慢性病管理领域。 RPM 能够在临床环境之外追踪血压和体重等生理参数，从而减少急诊就诊和住院次数。 2023 年，RPM 设备的进步将整合用于液体管理和监测的医用导管，从而改善心血管疾病 (CVD) 患者的照护。随着医疗保健提供者优先考虑经济高效、以患者为中心的解决方案，该领域预计将迎来成长。

聚合物基管材

硅胶、PVC 和聚氨酯等材料因其柔韧性、耐用性和生物相容性而被广泛应用于医用导管。到 2024 年，聚合物基导管的技术进步将提升导管和静脉输液管等应用的性能，从而推动医院和诊断中心的需求。

区域洞察

北美占据最大的市场占有率，这得益于高昂的医疗支出、先进的基础设施以及慢性病的高发生率。心臟病是美国的主要死因，这推动了医用导管的需求。亚太地区是成长最快的地区，这得益于政府改善医疗服务可近性的倡议，以及印度和中国等国家慢性病发病率的上升。紧随其后的是欧洲，得益于强大的医疗体系和高龄化社会。

市场挑战

挑战包括先进聚合物材料的高成本以及医用导管的严格监管要求，这些可能会延迟产品核准。此外，确保在各种应用中的生物相容性和耐用性需要持续的研发投入，这为较小的市场参与企业设置了障碍。

结论

预计到2028年，医用导管市场将迎来强劲成长，这得益于慢性病发病率上升、人口老化、政府医疗投入以及微创手术和药物输送系统的进步。北美和亚太地区是关键的成长区域，聚合物在导管创新中发挥关键作用。然而，高昂的成本和监管障碍需要策略创新来维持市场势头，并确保医用导管满足医疗保健产业不断变化的需求。

本报告的主要优点

• 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
• 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
• 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
• 受众范围广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

• 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
• 成长机会、挑战、供应链前景、法律规范与趋势分析
• 竞争定位、策略和市场占有率分析
• 收益成长和预测细分市场和区域分析（包括国家）
• 公司概况（尤其是财务状况和关键发展）

目录

第一章 引言

• 市场概览
• COVID-19 情景
• 市场定义
• 市场区隔

第二章调查方法

• 调查数据
• 先决条件

第三章执行摘要

• 调查重点

第四章 市场动态

• 市场驱动因素
• 市场限制
• 波特五力分析
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 业内竞争对手之间的竞争
• 产业价值链分析

第五章 全球医用导管市场（按材料）

• 介绍
• 聚氯乙烯
• 聚乙烯
• 聚丙烯
• 有机硅聚合物
• 生物可吸收聚合物
• 其他的

6. 全球医用导管市场类型

• 介绍
• 单腔
• 多重腔
• 共挤
• 锥形/凸形管
• 编织管
• 球囊管
• 热缩管

第七章全球医用导管市场（按应用）

• 介绍
• 药物输送
• 透析
• 静脉注射（IV）
• 导管
• 餵食管
• 生物製药实验室设备
• 其他的

8. 全球医用导管市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 英国
  • 德国
  • 法国
  • 其他的
• 中东和非洲
  • 阿拉伯聯合大公国
  • 以色列
  • 沙乌地阿拉伯
  • 其他的
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 台湾
  • 其他的

第九章：竞争格局及分析

• 主要企业和策略分析
• 新兴企业和市场盈利
• 合併、收购、协议和合作
• 供应商竞争力矩阵

第十章 公司简介

• Compagnie de Saint-Gobain SA
• Freudenberg Medical
• WL Gore & Associates, Inc.
• The Lubrizol Corporation
• Nordson Corporation

第106章 TE Connectivity有限公司

• 埃肯公司
• 特瑞堡公司

The Global Medical Tubing Market is expected to grow from USD 9.379 billion in 2025 to USD 13.593 billion in 2030, at a CAGR of 7.70%.

Increasing Prevalence of Chronic Diseases

The growing burden of chronic diseases, particularly cardiovascular diseases (CVDs), is a primary driver of the medical tubing market. According to the World Health Organization, CVDs account for 17.9 million deaths annually, representing 31% of global mortality. Risk factors such as tobacco use, unhealthy diets, and physical inactivity elevate the incidence of heart attacks and strokes, necessitating advanced medical interventions. Medical tubing is critical for fluid management, drainage, and drug delivery in cardiac care devices, such as those used to manage irregular heartbeats. The high prevalence of coronary heart disease, exacerbated by obesity, further fuels demand for medical tubing in diagnostic and therapeutic applications, driving market growth.

Aging Global Population

The rapidly aging population, particularly those over 65, is significantly increasing demand for medical tubing. This demographic is more susceptible to chronic conditions, requiring advanced healthcare solutions like catheters and infusion systems. The United Nations projects the global population aged 60 and above to reach 2.1 billion by 2050, with significant growth already evident by 2023. This demographic shift places pressure on healthcare systems, increasing health expenditure and boosting the need for medical tubing in applications ranging from chronic disease management to minimally invasive surgeries.

Government Investments in Healthcare

Favorable government policies and investments in healthcare infrastructure are propelling market growth. Initiatives to enhance healthcare access, particularly in emerging markets, are increasing the adoption of advanced medical devices that rely on medical tubing. For instance, in 2024, India's healthcare budget allocated significant funds to expand tertiary care facilities, driving demand for medical tubing in specialized treatments. Similarly, global efforts to improve healthcare delivery for chronic disease management are supporting market expansion.

Growth in Minimally Invasive Surgeries

The increasing adoption of minimally invasive surgical procedures is a key growth driver. These procedures, which rely heavily on medical tubing for catheters, endoscopes, and drug delivery systems, offer reduced recovery times and lower complication rates. The trend toward minimally invasive techniques, particularly in cardiovascular and oncology treatments, is boosting demand for specialized tubing materials that ensure precision and biocompatibility.

Expansion of the Drug Delivery Industry

The drug delivery sector is experiencing robust growth, driven by innovations in targeted delivery systems. Medical tubing plays a critical role in ensuring precise administration of medications, particularly in chronic disease management. In 2024, key market players introduced advanced tubing solutions for targeted drug delivery, enhancing therapeutic efficacy and patient outcomes, further propelling market growth.

Market Segmentation Analysis

Remote Patient Monitoring

The rise of remote patient monitoring (RPM) is a significant market driver, particularly for chronic disease management. RPM enables tracking of physiological parameters like blood pressure and weight outside clinical settings, reducing emergency visits and hospital stays. In 2023, advancements in RPM devices integrated medical tubing for fluid management and monitoring, improving care for CVD patients. This segment is expected to grow as healthcare providers prioritize cost-effective, patient-centric solutions.

Polymer-Based Tubing

The growing polymer industry is a key contributor to market growth, with materials like silicone, PVC, and polyurethane widely used in medical tubing for their flexibility, durability, and biocompatibility. In 2024, innovations in polymer-based tubing improved performance in applications like catheters and IV lines, driving demand in hospitals and diagnostic centers.

Regional Insights

North America holds the largest market share, driven by high healthcare expenditure, advanced infrastructure, and a high prevalence of chronic diseases. The U.S., with heart disease as a leading cause of death, leads in demand for medical tubing. The Asia-Pacific region is the fastest-growing, fueled by government initiatives to enhance healthcare access and rising chronic disease prevalence in countries like India and China. Europe follows closely, supported by robust healthcare systems and aging populations.

Market Challenges

Challenges include the high cost of advanced polymer materials and stringent regulatory requirements for medical-grade tubing, which can delay product approvals. Additionally, ensuring biocompatibility and durability in diverse applications requires continuous R&D investment, posing barriers for smaller market players.

Conclusion

The medical tubing market is set for robust growth through 2028, driven by the rising prevalence of chronic diseases, an aging population, government healthcare investments, and advancements in minimally invasive surgeries and drug delivery systems. North America and Asia-Pacific are key growth regions, with polymers playing a pivotal role in tubing innovations. However, high costs and regulatory hurdles necessitate strategic innovation to sustain market momentum, ensuring medical tubing meets the evolving needs of the healthcare industry.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Material

• Polyvinyl Chloride
• Polyethylene
• Polypropylene
• Silicone Polymers
• Bioabsorbable Polymers
• Others

By Structure

• Single Lumen
• Multiple Lumen
• Co-Extruded
• Tapered/ Bump Tubing
• Braided Tubing
• Balloon Tubing
• Heat Shrink Tubing

By Application

• Drug Delivery
• Dialysis
• Intravenous (IV)
• Catheters
• Feeding Tubes
• Biopharma lab equipment
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Others
• Middle East and Africa
• UAE
• Israel
• Saudi Arabia
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porters Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Medical Tubing Market Analysis, by Material

• 5.1. Introduction
• 5.2. Polyvinyl Chloride
• 5.3. Polyethylene
• 5.4. Polypropylene
• 5.5. Silicone Polymers
• 5.6. Bioabsorbable Polymers
• 5.7. Others

6. Global Medical Tubing Market Analysis, By Structure

• 6.1. Introduction
• 6.2. Single Lumen
• 6.3. Multiple Lumen
• 6.4. Co-Extruded
• 6.5. Tapered/Bump Tubing
• 6.6. Braided Tubing
• 6.7. Balloon Tubing
• 6.8. Heat Shrink Tubing

7. Global Medical Tubing Market Analysis, By Application

• 7.1. Introduction
• 7.2. Drug Delivery
• 7.3. Dialysis
• 7.4. Intravenous (IV)
• 7.5. Catheters
• 7.6. Feeding Tubes
• 7.7. Biopharma lab equipment
• 7.8. Others

8. Global Medical Tubing Market Analysis, by Geography

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. UK
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Others
• 8.5. Middle East and Africa
  • 8.5.1. United Arab Emirates
  • 8.5.2. Israel
  • 8.5.3. Saudi Arabia
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. South Korea
  • 8.6.6. Indonesia
  • 8.6.7. Thailand
  • 8.6.8. Taiwan
  • 8.6.9. Others

9. Competitive Environment and Analysis

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. Company Profiles

• 10.1. Compagnie de Saint-Gobain S.A.
• 10.2. Freudenberg Medical
• 10.3. W. L. Gore & Associates, Inc.
• 10.4. The Lubrizol Corporation
• 10.5. Nordson Corporation

106. TE Connectivity Ltd.

• 10.7. Elkem ASA
• 10.8 Trelleborg AB